We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+0.28%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$360B
AUM Growth
-$5.05B
Cap. Flow
-$2.61B
Cap. Flow %
-0.72%
Top 10 Hldgs %
13.81%
Holding
6,930
New
170
Increased
3,227
Reduced
2,806
Closed
155

Sector Composition

Rank Sector Weight
1 Technology 11.4%
2 Financials 10.07%
3 Consumer Discretionary 8.39%
4 Healthcare 7.69%
5 Communication Services 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BGSF icon
5151
BGSF Inc
BGSF
$59.5M
$310K ﹤0.01%
16,341
-13,838
-46% -$232K
ISL
5152
DELISTED
Aberdeen Israel Fund
ISL
$310K ﹤0.01%
15,873
+627
+4% +$12.8K
ONCT
5153
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$309K ﹤0.01%
124
+123
+12,300% +$274K
NPN
5154
DELISTED
Nuveen Pennsylvania Municipal Value Fund Common shares of beneficial interest
NPN
$309K ﹤0.01%
21,368
+300
+1% +$4.56K
DCPH
5155
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$307K ﹤0.01%
15,309
+911
+6% +$23.1K
MACK
5156
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$307K ﹤0.01%
48,575
+4,916
+11% +$40.7K
AMU
5157
DELISTED
ETRACS Alerian MLP Index ETN
AMU
$307K ﹤0.01%
20,365
-107
-0.5% -$1.84K
CLPR
5158
Clipper Realty
CLPR
$45.2M
$305K ﹤0.01%
36,018
+2,678
+8% +$24.2K
OPTN
5159
DELISTED
OptiNose
OPTN
$305K ﹤0.01%
1,014
+341
+51% +$94.5K
DDF
5160
DELISTED
Delaware Investments Dividend & Income Fund, Inc.
DDF
$305K ﹤0.01%
28,928
-679
-2% -$7.32K
FCO
5161
DELISTED
abrdn Global Income Fund
FCO
$303K ﹤0.01%
35,363
+3,318
+10% +$29.3K
VIVS
5162
VivoSim Labs
VIVS
$1.2M
$302K ﹤0.01%
1,224
+121
+11% +$35.3K
RNWK
5163
DELISTED
RealNetworks Inc
RNWK
$302K ﹤0.01%
98,476
+51,172
+108% +$161K
VUZI icon
5164
Vuzix
VUZI
$194M
$300K ﹤0.01%
54,374
+41,071
+309% +$335K
CVRS
5165
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$298K ﹤0.01%
217,533
-2,154
-1% -$2.5K
VNTR
5166
DELISTED
Venator Materials PLC
VNTR
$297K ﹤0.01%
16,407
-299,846
-95% -$6.32M
TRAK icon
5167
ReposiTrak
TRAK
$153M
$296K ﹤0.01%
33,816
+1,701
+5% +$16.8K
DLA
5168
DELISTED
Delta Apparel Inc.
DLA
$296K ﹤0.01%
16,444
-1,256
-7% -$24.3K
TLRA
5169
DELISTED
Telaria, Inc.
TLRA
$296K ﹤0.01%
78,686
+27,428
+54% +$119K
CBB.PRB
5170
DELISTED
Cincinnati Bell Inc. DEP SHS
CBB.PRB
$296K ﹤0.01%
6,028
+500
+9% +$24.8K
ESBA icon
5171
Empire State Realty Series ES
ESBA
$1.34B
$295K ﹤0.01%
17,548
-11,365
-39% -$205K
PNI
5172
PIMCO New York Municipal Income Fund II
PNI
$76.2M
$295K ﹤0.01%
27,418
-10,631
-28% -$118K
RESN
5173
DELISTED
Resonant Inc.
RESN
$295K ﹤0.01%
92,223
+84,873
+1,155% +$436K
ADXS
5174
DELISTED
Advaxis Inc
ADXS
$294K ﹤0.01%
11,617
-275
-2% -$10.3K
PFIG icon
5175
Invesco Fundamental Investment Grade Corporate Bond ETF
PFIG
$115M
$293K ﹤0.01%
11,750
-2,230
-16% -$56.1K

Similar funds

Morgan Stanley's Q1 2018 Portfolio in Review

As of Q1 2018, Morgan Stanley held 6,930 positions worth $360B, down 1.4% from $365B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 4.7%. Morgan Stanley opened 170 new positions and exited 155, leaving the 6,930-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Morgan Stanley's largest Q1 2018 buy was Nutrien: 1,554,481 shares worth $73.5M.
  • Morgan Stanley added most to iShares Russell 2000 ETF in Q1 2018, an estimated $1.27B increase.
  • Morgan Stanley's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.33B.
  • Morgan Stanley fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $86M.
  • Morgan Stanley's ten largest holdings make up 14% of its $360B portfolio in Q1 2018.
  • Morgan Stanley opened 170 new positions and closed 155 in Q1 2018.
  • Morgan Stanley's portfolio value fell 1.4% quarter-over-quarter to $360B.

Based on Morgan Stanley's 13F filing for Q1 2018, filed 14 May 2018.